News

Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys.
Experts discuss how weight loss can trigger temporary hair loss, with hairstylists and an endocrinologist providing insights ...
Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism ...
Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.
Novo Nordisk will begin phase 3 trials for amycretin in early 2026 following promising weight loss data and regulatory ...
Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...
The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...
Novo Nordisk’s shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe’s ...
Drugmaker Novo Nordisk is once again Europe's largest company by market capitalisation, rising above German software firm SAP ...
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...
Bernie Sanders and Angus King introduced a bill that would ban pharmaceutical manufacturers from using direct-to-consumer ...